- Home
- AQST vs RRBI Comparison
AQST vs RRBI Comparison
Compare AQST & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RRBI
- Stock Information
- Founded
- AQST 2004
- RRBI 1998
- Country
- AQST United States
- RRBI United States
- Employees
- AQST N/A
- RRBI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RRBI Hotels/Resorts
- Sector
- AQST Health Care
- RRBI Consumer Discretionary
- Exchange
- AQST Nasdaq
- RRBI Nasdaq
- Market Cap
- AQST 390.4M
- RRBI 406.6M
- IPO Year
- AQST 2018
- RRBI 2019
- Fundamental
- Price
- AQST $3.96
- RRBI $60.54
- Analyst Decision
- AQST Strong Buy
- RRBI Buy
- Analyst Count
- AQST 7
- RRBI 1
- Target Price
- AQST $11.29
- RRBI $67.00
- AVG Volume (30 Days)
- AQST 1.1M
- RRBI 14.2K
- Earning Date
- AQST 08-11-2025
- RRBI 07-30-2025
- Dividend Yield
- AQST N/A
- RRBI 0.81%
- EPS Growth
- AQST N/A
- RRBI 23.33
- EPS
- AQST N/A
- RRBI 5.67
- Revenue
- AQST $54,228,000.00
- RRBI $115,623,000.00
- Revenue This Year
- AQST N/A
- RRBI $5.20
- Revenue Next Year
- AQST $51.62
- RRBI $5.49
- P/E Ratio
- AQST N/A
- RRBI $10.45
- Revenue Growth
- AQST 5.29
- RRBI 10.35
- 52 Week Low
- AQST $2.12
- RRBI $46.33
- 52 Week High
- AQST $5.80
- RRBI $64.65
- Technical
- Relative Strength Index (RSI)
- AQST 50.64
- RRBI 40.07
- Support Level
- AQST $3.73
- RRBI $58.67
- Resistance Level
- AQST $4.10
- RRBI $61.44
- Average True Range (ATR)
- AQST 0.22
- RRBI 1.42
- MACD
- AQST -0.07
- RRBI -0.66
- Stochastic Oscillator
- AQST 17.42
- RRBI 16.91
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.